Actisite® periodontal fiber is indicated as an adjunct to scaling and root planing for reduction of pocket depth and bleeding on probing in patients with adult periodontitis.

Treatment with Actisite is a component of an intervention program which includes good oral hygiene and scaling and root planing.

Effectiveness of repeated fiber applications in a site has not been studied.

The effects of Actisite on bone loss, tooth mobility, or tooth loss from periodontal disease has not been established.

Actisite periodontal fiber for 10 days is indicated as an adjunct to scaling and root planing. Repeated fiber applications have not been studied. Actisite fiber should be inserted into the periodontal pocket until the pocket is filled. The length of fiber used will vary with pocket depth and contour. The fiber should be placed to closely approximate the pocket anatomy and should be in contact with the base of the pocket. An appropriate cyanoacrylate adhesive should be used to help secure the fiber in the pocket.

When placed within a periodontal pocket, Actisite fiber provides continuous release of tetracycline for 10 days. At the end of 10 days of treatment, all fibers must be removed. Fibers lost before 7 days should be replaced.

Actisite periodontal fiber is available in cartons containing 4 fibers and 10 fibers. Each individually packaged, yellow fiber is 23 cm (9 inches) long and contains 12.7 mg of Actisite.

NDC 17314-4800-4 (4 Fiber carton)
NDC 17314-4800-1 (10 Fiber carton)

Store at controlled room temperature 15^o-30^oC (59^o-86^oF).

Caution: Federal law prohibits dispensing without prescription.

Manufactured by
ALZA Corporation,
Palo Alto, CA 94304 USA
For: P&G/ALZA

For product information call: 1-800-ACTISITE

To place an order call: 1-800-543-2577

© Procter & Gamble and ALZA Corporation 4/94
All rights reserved

Next: Actisite - Side Effects & Drug Interactions »
« Previous: Actisite - Drug Description

• « previous
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• next »

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Bookmark this page: